Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Spain
  4. Bolsas y Mercados Espanoles
  5. Grifols, S.A.
  6. Summary
    GRF   ES0171996087

GRIFOLS, S.A.

(GRF)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Bolsas Y Mercados Espanol…
10/22/2021 10/25/2021 10/26/2021 10/27/2021 10/28/2021 Date
20.2(c) 20.44(c) 20.33(c) 19.85(c) 19.84 Last
717 568 908 961 498 535 651 615 607 183 Volume
-0.93% +1.19% -0.54% -2.36% -0.05% Change
More quotes
Estimated financial data (e)
Sales 2021 5 283 M 6 131 M 6 131 M
Net income 2021 556 M 646 M 646 M
Net Debt 2021 6 052 M 7 024 M 7 024 M
P/E ratio 2021 24,0x
Yield 2021 1,61%
Sales 2022 5 741 M 6 663 M 6 663 M
Net income 2022 716 M 831 M 831 M
Net Debt 2022 5 880 M 6 824 M 6 824 M
P/E ratio 2022 18,7x
Yield 2022 1,76%
Capitalization 11 425 M 13 240 M 13 259 M
EV / Sales 2021 3,31x
EV / Sales 2022 3,01x
Nbr of Employees 23 431
Free-Float 79,7%
More Financials
Company
Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. It organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end... 
Sector
Pharmaceuticals
Calendar
11/10Earnings Release
More about the company
Ratings of Grifols, S.A.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about GRIFOLS, S.A.
10/26GRIFOLS S A : earns approval for the voluntary public tender offer of Biotest and advances..
PU
10/26GRIFOLS S A : October 26, 2021Grifols earns approval for the voluntary public tender offer..
PU
10/20GLOBAL MARKETS LIVE : Kering, Netflix, Roche, United Airlines, Xiaomi...
10/19GRIFOLS S A : Egypt Launch 1st African Plasma-Supply Platform
MT
10/19Grifols and Egypt Inaugurate First African Plasma-Supply Platform, in Cairo, as Part of..
CI
10/19GRIFOLS S A : and Egypt inaugurate first African plasma-supply platform, in Cairo, as part..
PU
10/18European ADRs Move Lower in Monday Trading
MT
10/13GRIFOLS S A : increases access to plasma-derived therapies as part of its commitment to do..
PU
10/13GRIFOLS S A : October 13, 2021Grifols increases access to plasma-derived therapies as part..
PU
10/12European ADRs Slightly Higher Tuesday Morning, Led by Biotechs
MT
10/11European ADRs Move Higher in Monday Trading
MT
10/08European ADRs Move Higher in Friday Trading
MT
10/06GRIFOLS S A : Citigroup Upgrades Grifols to Buy from Neutral
MT
10/06GRIFOLS S A : divests its hemostasis technology business for USD 25 million
PU
10/06GRIFOLS S A : October 6, 2021Grifols divests its hemostasis technology business for USD 25..
PU
More news
News in other languages on GRIFOLS, S.A.
10/26EN DIRECTO DESDE LOS MERCADOS : Enagás, Grifols, Nordea, Samsung Heavy, Facebook, UBS, Gee..
10/26Tesla y Facebook en modo fuego cruzado
10/26GRIFOLS S A : recibe la aprobación a la OPA voluntaria sobre Biotest y avanza en su estrat..
10/26GRIFOLS S A : 26 octubre 2021Grifols recibe la aprobación a la OPA voluntaria sobre Biotes..
10/20EN DIRECTO DESDE LOS MERCADOS : Grifols, Iberdrola, Tencent, ASML, Nestlé, Burberry, Faceb..
More news
Analyst Recommendations on GRIFOLS, S.A.
More recommendations
Chart GRIFOLS, S.A.
Duration : Period :
Grifols, S.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GRIFOLS, S.A.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Last Close Price 19,85 €
Average target price 26,66 €
Spread / Average Target 34,3%
EPS Revisions
Managers and Directors
Raimon Grifols Roura Joint Chief Executive Officer & Executive Director
Victor Grifols Deu Joint Chief Executive Officer & Executive Director
Alfredo Arroyo Guerra Chief Financial Officer & Vice President
VÝctor Grifols Roura Non-Executive Chairman
Xavier Sueiras Gil Chief Information Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
GRIFOLS, S.A.-16.88%13 240
CSL LIMITED5.58%101 238
WUXI BIOLOGICS (CAYMAN) INC.14.30%65 479
SAMSUNG BIOLOGICS CO.,LTD.8.72%49 817
ALEXION PHARMACEUTICALS, INC.0.00%40 336
BIOGEN INC.10.72%39 826